Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 GBX | 0.00% | +7.69% | -37.50% |
Mar. 28 | Kanabo shares soar after company announces UK mental health service | AN |
Mar. 25 | Kanabo shares higher as Germany reclassifies medical cannabis | AN |
Sales 2021 | 73K 92.15K | Sales 2022 | 603K 761K | Capitalization | 8.04M 10.14M |
---|---|---|---|---|---|
Net income 2021 | -4M -5.05M | Net income 2022 | -6M -7.57M | EV / Sales 2021 | 648 x |
Net cash position 2021 | 4.5M 5.68M | Net cash position 2022 | 3.01M 3.8M | EV / Sales 2022 | 8.33 x |
P/E ratio 2021 |
-9.98
x | P/E ratio 2022 |
-1.15
x | Employees | 23 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 61.92% |
1 week | +7.69% | ||
Current month | -2.78% | ||
1 month | -2.78% | ||
3 months | -2.78% | ||
6 months | +2.94% | ||
Current year | -37.50% |
Managers | Title | Age | Since |
---|---|---|---|
Avihu Tamir
CEO | Chief Executive Officer | - | - |
Assaf Vardimon
DFI | Director of Finance/CFO | 46 | - |
Ophir Shimshi
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Mattioli
CHM | Chairman | 62 | 23-05-08 |
David Tsur
BRD | Director/Board Member | 73 | 21-06-27 |
Sharon Malka
BRD | Director/Board Member | 51 | 23-05-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.75 | 0.00% | 276,892 |
24-03-27 | 1.75 | -2.78% | 249,771 |
24-03-26 | 1.8 | -2.70% | 533,940 |
24-03-25 | 1.85 | +13.85% | 1,205,163 |
24-03-22 | 1.625 | 0.00% | 409,990 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-37.50% | 13.97M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |